US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown
biotech · Solid Tumor Malignancies · FENC
FENNEC PHARMACEUTICALS
FENNEC PHARMACEUTICALS INC.
FENNEC PHARMACEUTICALS drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Research Triangle Park, USA HQ
1996 Founded
54 Employees
Public company Type
FENC · NYSE Ticker
Company details
- Status
- Public
- HQ
- Research Triangle Park, USA
- Founded
- 1996
- Employees
- 54
- Programs
- 1
- Drugs
- 1
- Patents
- 8
FENNEC PHARMACEUTICALS pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
FENNEC PHARMACEUTICALS drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.